UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells.

Ting Zhang, Linglin Zhao, Shengyuan Zeng, Lu Bai, Junxia Chen, Zheng Zhang, Yalan Wang, Changzhu Duan
Author Information
  1. Ting Zhang: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
  2. Linglin Zhao: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
  3. Shengyuan Zeng: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
  4. Lu Bai: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
  5. Junxia Chen: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
  6. Zheng Zhang: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
  7. Yalan Wang: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
  8. Changzhu Duan: Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.

Abstract

Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is a multi-domain E3 ubiquitin ligase which is involved in epigenetic regulation and plays an essential role in tumorigenesis. However, the role of UHRF2 in histone H3 acetylation has not yet been fully elucidated and few studies have reported its role in hepatocellular carcinoma (HCC). In this study, we examined the correlation between UHRF2 and acetylated H3 in HCC. Immunohistochemistry and western blot analysis demonstrated that the levels of histone H3 lysine 9 acetylation (H3K9ac) and histone H3 lysine 14 acetylation (H3K14ac) were higher in the HCC tissues and HepG2 HCC cells compared with the adjacent non-tumor tissues and L02 normal cells. The level of UHRF2 was higher in the HCC tissues compared with the adjacent non-tumor tissues, but its expression did not exhibit a significant difference between the HepG2 HCC cells and the L02 normal cells. In addition, when comparing the HCC tissues, a higher expression of UHRF2 correlated with a lower expression of H3K9ac in the HCC tissues. The overexpression of UHRF2 increased the expression of H3K9ac in L02 normal cells (P<0.01), but decreased the expression of H3K9ac in HepG2 cancer cells (P<0.05). Moreover, immunofluorescence staining and co-immunoprecipitation assay indicated that UHRF2 co-localized and interacted with H3K9ac in L02 and HepG2 cells and the plant homeodomain (PHD) finger domain was the key domain for UHRF2 directly binding to H3K9ac. Taken together, these results suggest that UHRF2 decreases the expression of H3K9ac in HepG2 HCC cells and interacts with it through the PHD domain.

References

  1. Nucleic Acids Res. 2011 Nov;39(21):9061-71 [PMID: 21813457]
  2. Annu Rev Biochem. 2007;76:75-100 [PMID: 17362198]
  3. Nat Genet. 2008 Jul;40(7):897-903 [PMID: 18552846]
  4. Cell. 2005 Aug 26;122(4):517-27 [PMID: 16122420]
  5. DNA Cell Biol. 2015 May;34(5):327-32 [PMID: 25664994]
  6. Cell Res. 2011 Dec;21(12 ):1723-39 [PMID: 22064703]
  7. FEBS Lett. 2009 Nov 3;583(21):3501-7 [PMID: 19818775]
  8. Cancer Res. 2009 May 1;69(9):3802-9 [PMID: 19366799]
  9. Mol Cell. 2011 Jul 22;43(2):275-84 [PMID: 21777816]
  10. Biotechnol Lett. 2012 Jan;34(1):29-36 [PMID: 22072112]
  11. BMC Genomics. 2012 Aug 24;13:424 [PMID: 22920947]
  12. Cancer. 2007 May 15;109(10):2132-41 [PMID: 17407132]
  13. J Biol Chem. 2007 Feb 16;282(7):4408-16 [PMID: 17166833]
  14. Mol Cell Biol. 2008 Jan;28(2):705-17 [PMID: 17967883]
  15. Oncogene. 2012 Jan 19;31(3):333-41 [PMID: 21666724]
  16. J Cell Biochem. 2011 Sep;112(9):2585-93 [PMID: 21598301]
  17. FEBS Lett. 2012 Jun 4;586(11):1570-83 [PMID: 22673569]
  18. Mol Cell Biol. 2004 Mar;24(6):2526-35 [PMID: 14993289]
  19. World J Gastroenterol. 2014 Jun 28;20(24):7830-48 [PMID: 24976721]
  20. Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3687-95 [PMID: 23236169]
  21. CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29 [PMID: 22237781]
  22. Hum Pathol. 2012 Sep;43(9):1425-35 [PMID: 22406368]
  23. PLoS One. 2013 Aug 09;8(8):e71517 [PMID: 23951179]
  24. Biochem Biophys Res Commun. 2013 Nov 8;441(1):65-70 [PMID: 24134842]
  25. Pharmacol Ther. 2007 Sep;115(3):419-34 [PMID: 17658611]
  26. BMC Genomics. 2010 Apr 21;11:257 [PMID: 20409305]
  27. Asian Pac J Cancer Prev. 2012;13(10 ):5137-42 [PMID: 23244124]
  28. Int J Clin Exp Pathol. 2014 Apr 15;7(5):2496-507 [PMID: 24966962]
  29. World J Gastroenterol. 2014 Jan 14;20(2):333-45 [PMID: 24574704]
  30. Cancer Lett. 2012 Jan 28;314(2):223-31 [PMID: 22018986]
  31. Oncol Rep. 2014 Apr;31(4):1802-10 [PMID: 24573556]
  32. Lab Invest. 2013 Sep;93(9):983-90 [PMID: 23917878]

MeSH Term

Acetylation
Carcinoma, Hepatocellular
Hep G2 Cells
Histones
Humans
Liver Neoplasms
Lysine
Protein Binding
Protein Domains
Protein Transport
Sequence Deletion
Structure-Activity Relationship
Ubiquitin-Protein Ligases

Chemicals

Histones
UHRF2 protein, human
Ubiquitin-Protein Ligases
Lysine

Word Cloud

Created with Highcharts 10.0.0UHRF2HCCH3K9accellsexpressiontissuesHepG2PHDL02domainrolehistone H3highernormalfingerhepatocellularacetylation comparedadjacentnon-tumorcells P<0decreasesUbiquitin-likeringdomains 2multi-domain E3ubiquitinligaseinvolvedepigeneticregulationplaysessentialtumorigenesisHoweveracetylationyetfullyelucidatedstudiesreportedcarcinoma studyexaminedcorrelationacetylated H3Immunohistochemistrywesternblotanalysisdemonstratedlevelslysine 9lysine 14H3K14aclevelexhibitsignificantdifferenceadditioncomparingcorrelatedloweroverexpressionincreased01decreasedcancer05Moreoverimmunofluorescencestainingco-immunoprecipitationassayindicatedco-localizedinteractedplanthomeodomain keydirectlybindingTakentogetherresultssuggestinteractsinteractingSRA/YDGcarcinoma

Similar Articles

Cited By